Biological and clinical significance of anti-Müllerian hormone determination in blood serum of the mare

Theriogenology

Volumn 76, Issue 8, 2011, Pages 1393-1403

  Almeida, J ^a   Ball, B A ^a   Conley, A J ^a   Place, N J ^b   Liu, I K M ^a   Scholtz, E L ^a   Mathewson, L ^a   Stanley, S D ^c   Moeller, B C ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Obstetrics Gynecology   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anti M llerian hormone; Equine estrous cycle; Granulosa cell tumor; Ovarian follicle; Ovary; Pregnancy

Indexed keywords

ANTI MULLERIAN HORMONE RECEPTOR; ANTI-MULLERIAN HORMONE RECEPTOR; MUELLERIAN INHIBITING FACTOR; RECEPTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TUMOR MARKER;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CHEMISTRY; CYST FLUID; ENZYME IMMUNOASSAY; ESTRUS CYCLE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GRANULOSA CELL TUMOR; HORSE; HORSE DISEASE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; OVARIECTOMY; OVULATION; PHYSIOLOGY; PREGNANCY; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY;

ANIMALS; ANTI-MULLERIAN HORMONE; CYST FLUID; ESTROUS CYCLE; FEMALE; GENE EXPRESSION REGULATION; GRANULOSA CELL TUMOR; HORSE DISEASES; HORSES; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; OVARIECTOMY; OVULATION; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PEPTIDE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EQUIDAE;

EID: 80053561911     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2011.06.008     Document Type: Article

References (40)

1. Cate R.L., Mattaliano R.J., Hession C., Tizard R., Farber N.M., Cheung A., Ninfa E.G., Frey A.Z., Gash D.J., Chow E.P., et al. Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells. Cell 1986, 45:685-698.
2. Josso N., Picard J.Y. Anti-Mullerian hormone. Physiol Rev 1986, 66:1038-1090.
3. Hirobe S., He W.W., Lee M.M., Donahoe P.K. Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology 1992, 131:854-862.
4. Taketo T., Saeed J., Manganaro T., Takahashi M., Donahoe P.K. Mullerian inhibiting substance production associated with loss of oocytes and testicular differentiation in the transplanted mouse XX gonadal primordium. Biol Reprod 1993, 49:13-23.
5. Rey R., Lukas-Croisier C., Lasala C., Bedecarras P. AMH/MIS: what we know already about the gene, the protein and its regulation. Mol Cell Endocrinol 2003, 211:21-31.
6. Durlinger A.L., Kramer P., Karels B., de Jong F.H., Uilenbroek J.T., Grootegoed J.A., Themmen A.P. Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 1999, 140:5789-5796.
7. Baarends W.M., Uilenbroek J.T., Kramer P., Hoogerbrugge J.W., van Leeuwen E.C., Themmen A.P., Grootegoed J.A. Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 1995, 136:4951-4962.
8. Weenen C., Laven J.S., Von Bergh A.R., Cranfield M., Groome N.P., Visser J.A., Kramer P., Fauser B.C., Themmen A.P. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004, 10:77-83.
9. Wunder D.M., Bersinger N.A., Yared M., Kretschmer R., Birkhauser M.H. Statistically significant changes of antimullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertil Steril 2008, 89:927-933.
10. Sowers M., McConnell D., Gast K., Zheng H., Nan B., McCarthy J.D., Randolph J.F. Anti-Mullerian hormone and inhibin B variability during normal menstrual cycles. Fertil Steril 2010, 94:1482-1486.
11. Tsepelidis S., Devreker F., Demeestere I., Flahaut A., Gervy C., Englert Y. Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod 2007, 22:1837-1840.
12. La Marca A., Giulini S., Orvieto R., De Leo V., Volpe A. Anti-Mullerian hormone concentrations in maternal serum during pregnancy. Hum Reprod 2005, 20:1569-1572.
13. Freour T., Mirallie S., Bach-Ngohou K., Denis M., Barriere P., Masson D. Measurement of serum anti-Mullerian hormone by Beckman Coulter ELISA and DSL ELISA: comparison and relevance in assisted reproduction technology (ART). Clin Chim Acta 2007, 375:162-164.
14. Al-Qahtani A., Muttukrishna S., Appasamy M., Johns J., Cranfield M., Visser J.A., Themmen A.P., Groome N.P. Development of a sensitive enzyme immunoassay for anti-Mullerian hormone and the evaluation of potential clinical applications in males and females. Clin Endocrinol (Oxf) 2005, 63:267-273.
15. Ball B.A., Conley A.J., MacLaughlin D.T., Grundy S.A., Sabeur K., Liu I.K. Expression of anti-Mullerian hormone (AMH) in equine granulosa-cell tumors and in normal equine ovaries. Theriogenology 2008, 70:968-977.
16. Long W.Q., Ranchin V., Pautier P., Belville C., Denizot P., Cailla H., Lhomme C., Picard J.Y., Bidart J.M., Rey R. Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 2000, 85:540-544.
17. La Marca A., Volpe A. The Anti-Mullerian hormone and ovarian cancer. Hum Reprod Update 2007, 13:265-273.
18. Rey R., Sabourin J.C., Venara M., Long W.Q., Jaubert F., Zeller W.P., Duvillard P., Chemes H., Bidart J.M. Anti-Mullerian hormone is a specific marker of sertoli- and granulosa-cell origin in gonadal tumors. Hum Pathol 2000, 31:1202-1208.
19. McCue P.M. Neoplasia of the female reproductive tract. Vet Clin North Am Equine Pract 1998, 14:505-515.
20. Sundberg J.P., Burnstein T., Page E.H., Kirkham W.W., Robinson F.R. Neoplasms of Equidae. J Am Vet Med Assoc 1977, 170:150-152.
21. MacLachlan N.J. Ovarian disorders in domestic animals. Environ Health Perspect 1987, 73:27-33.
22. Neto A.C., Ball B.A., Browne P., Conley A.J. Cellular localization of androgen synthesis in equine granulosa-theca cell tumors: immunohistochemical expression of 17alpha-hydroxylase/17,20-lyase cytochrome P450. Theriogenology 2010, 74:393-401.
23. Gift L.J., Gaughan E.M., Schoning P. Metastatic granulosa cell tumor in a mare. J Am Vet Med Assoc 1992, 200:1525-1526.
24. McCue P.M., Roser J.F., Munro C.J., Liu I.K., Lasley B.L. Granulosa cell tumors of the equine ovary. Vet Clin North Am Equine Pract 2006, 22:799-817.
25. Roser J.F., McCue P.M., Hoye E. Inhibin activity in the mare and stallion. Domest Anim Endocrinol 1994, 11:87-100.
26. Stabenfeldt G.H., Hughes J.P., Kennedy P.C., Meagher D.M., Neely D.P. Clinical findings, pathological changes and endocrinological secretory patterns in mares with ovarian tumours. J Reprod Fertil Suppl 1979, 27:277-285.
27. Munro C., Stabenfeldt G. Development of a microtitre plate enzyme immunoassay for the determination of progesterone. J Endocrinol 1984, 101:41-49.
28. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
29. Yuan J.S., Reed A., Chen F., Stewart C.N. Statistical analysis of real-time PCR data. BMC Bioinformatics 2006, 7:85.
30. Cook C.L., Siow Y., Taylor S., Fallat M.E. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000, 73:859-861.
31. Hehenkamp W.J., Looman C.W., Themmen A.P., de Jong F.H., Te Velde E.R., Broekmans F.J. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006, 91:4057-4063.
32. La Marca A., Malmusi S., Giulini S., Tamaro L.F., Orvieto R., Levratti P., Volpe A. Anti-Mullerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation. Hum Reprod 2004, 19:2738-2741.
33. Jayaprakasan K., Deb S., Batcha M., Hopkisson J., Johnson I., Campbell B., Raine-Fenning N. The cohort of antral follicles measuring 2-6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Mullerian hormone and response to controlled ovarian stimulation. Fertil Steril 2010, 94:1775-1781.
34. Fanchin R., Schonauer L.M., Righini C., Frydman N., Frydman R., Taieb J. Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 2003, 18:328-332.
35. Nelson S.M., Stewart F., Fleming R., Freeman D.J. Longitudinal assessment of antimullerian hormone during pregnancy-relationship with maternal adiposity, insulin, and adiponectin. Fertil Steril 2010, 93:1356-1358.
36. Vigier B., Tran D., du Buisson F., Heyman Y., Josso N. Use of monoclonal antibody techniques to study the ontogeny of bovine anti-Mullerian hormone. Reproduction 1983, 69:207-214.
37. Gustafson M.L., Lee M.M., Scully R.E., Moncure A.C., Hirakawa T., Goodman A., Muntz H.G., Donahoe P.K., MacLaughlin D.T., Fuller A.F. Mullerian inhibiting substance as a marker for ovarian sex-cord tumor. N Engl J Med 1992, 326:466-471.
38. Rey R.A., Lhomme C., Marcillac I., Lahlou N., Duvillard P., Josso N., Bidart J.M. Anti-mullerian hormone as a serum marker of granulosa cell tumorsof the ovary: comparative study with serum alpha-inhibin and estradiol. Am J Obstet Gynecol 1996, 174:958-965.
39. Bailey M.T., Troedsson M.H., Wheato J.E. Inhibin concentrations in mares with granulosa cell tumors. Theriogenology 2002, 57:1885-1895.
40. Zelli R., Sylla L., Monaci M., Stradaioli G., Sibley L.E., Roser J.F., Munro C., Liu I.K. Gonadotropin secretion and pituitary responsiveness to GnRH in mares with granulosa-theca cell tumor. Theriogenology 2006, 66:1210-1218.